Drug intelligence / Profile preview

gamma-irradiated amniotic membrane

Development stage
Unknown
Lead developer
Egyptian Atomic Energy Authority
Administration
Surgical Implantation
01

Overview

Gamma-irradiated amniotic membrane is a biological tissue graft derived from the human placenta, specifically the innermost layer of the fetal membranes. For therapeutic use, the tissue undergoes a preservation and sterilization process that involves decellularization, lyophilization (freeze-drying), and terminal sterilization using gamma radiation (typically at a dose of 25 kGy). This process ensures the material is sterile and shelf-stable for up to five years while maintaining the integrity of the extracellular matrix. It acts as a biological scaffold rich in collagen, fibronectin, and laminin, facilitating tissue regeneration, reducing inflammation, and providing structural support. In gynecological surgery, it is used as an alternative to synthetic mesh in procedures like posterior colporrhaphy to repair pelvic organ prolapse defects, such as rectoceles, by reinforcing the rectovaginal fascia.

Other names
gamma-irradiated sterilized freeze-dried amnion graftlyophilized amniotic membraneacellular amniotic membranesterilized lyophilized amniotic membrane

Beyond the preview

Go deeper on gamma-irradiated amniotic membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamma-irradiated amniotic membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call